James Kean - Concepedia

Author

James Kean

Swinburne University of Technology ORCID

Also Known As

J. Kean, James D Kean, James D. Kean, James Kean, Kean, James

Publications

724

Citations

H-Index

Concepts

All Affiliations

Swinburne University of Technology The University of Melbourne

About

James Kean is an author at Swinburne University of Technology specializing in medicine, health sciences, and pain management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	253
2	Education	1	1	202
3	Health Sciences	1	1	51
4	Anesthesia	1	1	51
5	Child Development	1	1	202

James Kean

Publications

460

Citations

H-Index

Page 1

	Year	Citations
The Development of Preschool Children of Heroin-Addicted Mothers: A Controlled Study Geraldine S. Wilson, Richard McCreary, James Kean, PEDIATRICS Family MedicineMccarthy ScalesSubstance UseEducationPreschool Development	1979	202
An Acute, Double‐Blind, Placebo‐Controlled Crossover Study of 320 mg and 640 mg Doses of a Special Extract of <i>Bacopa monnieri</i> (CDRI 08) on Sustained Cognitive Performance Luke A. Downey, James Kean, Fiona Nemeh, Phytotherapy Research	2012	63
Continuous interscalene infusion and single injection using levobupivacaine for analgesia after surgery of the shoulder James Kean, C.A. Wigderowitz, D.M. Coventry Journal of Bone and Joint Surgery - British Volume Pain MedicineSurgery20-Gauge Polyamide CatheterOrthopaedic SurgeryPain Management	2006	51
A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) James Kean, Jordy Kaufman, Justine Lomas, Nutrients	2015	39
Digital technology for addressing cognitive impairment in recent-onset psychosis: A perspective Imogen Bell, Roos Pot-Kolder, Stephen J. Wood, Schizophrenia Research Cognition	2022	33
Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial James Kean, Jerome Sarris, Andrew Scholey, Psychopharmacology	2016	32
A Randomized, Double-Blind Study Assessing Changes in Cognitive Function in Indian School Children Receiving a Combination of Bacopa monnieri and Micronutrient Supplementation vs. Placebo Tora Mitra-Ganguli, Soumik Kalita, Sakshi Bhushan, Frontiers in Pharmacology	2017	18
Effects of <i>Bacopa monnieri</i> (<scp>CDRI</scp> 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double‐blind, placebo‐controlled trial James Kean, Luke A. Downey, Jerome Sarris, Phytotherapy Research	2022	12
A randomized controlled trial investigating the effects of PCSO-524®, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6–14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066 James Kean, David Camfield, Jerome Sarris, Nutrition Journal	2013	10

Page 1